NHS Scotland chooses Trustmarque and KenSci to trial innovative predictive technology for chronic obstructive pulmonary disease
In a drive to improve the care of patients suffering from long-term illnesses, NHS Scotland has embarked on an innovative research project with partners Trustmarque and KenSci, to create a trial risk prediction platform which aims to help predict pulmonary risk and improve care for patients suffering from chronic obstructive pulmonary disease (COPD).
